Cel-Sci Corporation

Day range

$1.51 – $1.83

Open

$1.71

Prev close

$1.64

Volume

91.92K

Market cap

$28.85M

Shares out

17.48M

P/E

—

P/S

—

P/B

2.63

P/FCF

—

ROE

-207.2%

ROA

-106.3%

Debt/Equity

0.57

Div yield

0.00%

As of Oct 23, 2026

• Annual meeting resultsAug 17, 2026

  The annual meeting of CEL-SCI's shareholders was held on August 14, 2026. At the meeting the following persons were elected as directors for the upcoming year: Geert Kersten, Bruno Baillavoine, Robert Watson with vote tallies provided.

• Underwriting agreementJun 16, 2026

  Pursuant to the terms of the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash fee equal to 7.0% of the gross proceeds of the Offering and to reimburse the Placement Agent for certain of its expenses in an aggregate amount up to $67,000.

• Partnership or collaborationMay 14, 2026

  strategic partnership, distribution, and revenue sharing agreement with Amarox for regulatory affairs, marketing and potential commercialization of Multikine (Leukocyte Interleukin, Injection) in the treatment of head and neck cancer in Saudi Arabia, with an optional extension for the Gulf Cooperation Council (GCC) countries

• Underwriting agreementMay 13, 2026

  On May 11, 2026, CEL-SCI Corporation entered into a Placement Agency Agreement with ThinkEquity LLC. Pursuant to the terms of the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash fee equal to 7.0% of the gross proceeds of the offering and to reimburse the Placement Agent for certain of its expenses in an aggregate amount up to $150,000.

• Shareholder rights planNov 24, 2025

  On November 18, 2025, the Board of Directors of CEL-SCI Corporation (the "Company") approved certain revisions to the Company's Shareholder Rights Agreement. The Shareholder Rights Agreement, as revised on November 18, 2025, is attached as Exhibit 4 to this report.

Days to cover

4.1

Short interest

592.42K

Avg volume

143.19K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• 3 Interesting Emerging Growth Stock Ideas From the 2024 Think Equity Conference
  positiveInvesting.com· Nov 4, 2024
• Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
  Benzinga· Dec 4, 2023
• Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
  Benzinga· Jul 18, 2023
• US Stocks Mixed; Bank of America Tops Q2 Views
  Benzinga· Jul 18, 2023
• Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket
  Benzinga· Jul 18, 2023